Posts by: Margarida Azevedo

Margarida Azevedo

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

November 4, 2015November 4, 2015

Study Investigates Association Between Benign Prostatic Hyperplasia And Metabolic Syndrome

News

A relationship between metabolic syndrome (MetS) and the development of benign prostatic hyperplasia (BPH) has been suggested in the past, but causality has not yet been proved. In a new ... Read more

October 30, 2015October 31, 2015

Current Complementary And Alternative Medicines For BPH Treatment

News

Benign prostatic hyperplasia (BPH), the non-malignant enlargement of the prostate, is traditionally treated by a series of medical or surgical methods, with extensive research currently in progress to develop new ... Read more

October 29, 2015October 29, 2015

New Minimally Invasive Therapies for Benign Prostatic Hyperplasia in Works

News

Management of benign prostatic hyperplasia (BPH) is traditionally administered via surgical methods such as transurethral resection of the prostrate (TURP). Though fairly successful and safe, these techniques are operator dependent and often ... Read more